首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and evaluation of some novel dibenzo(b,d)furan carboxylic acids as potential anti-diabetic agents.
【24h】

Synthesis and evaluation of some novel dibenzo(b,d)furan carboxylic acids as potential anti-diabetic agents.

机译:某些新型二苯并(b,d)呋喃羧酸作为潜在的抗糖尿病药的合成与评价。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of novel dibenzo[b,d]furan mono-carboxylic acid derivatives were synthesized, characterized and evaluated for their ability to inhibit Protein Tyrosine Phosphatase 1B (PTP1B) in vitro in order to use them as potential anti-diabetic agents. Structure-activity relationship study led to the identification of potent compound 5 E which inhibited PTP1B with IC(50) value of 82+/-0.43 nM. Compound 5 E was screened in vivo as drug candidate for anti-diabetic activity using rosiglitazone maleate as the standard. Compound 5 E showed significant reduction in body weight, fed-state whole blood glucose (WBG), fasting WBG, plasma glucose and plasma cholesterol levels and non-significant reduction in fasting plasma triglyceride levels in ob/ob mice.
机译:合成,表征和评估了其在体外抑制蛋白酪氨酸磷酸酶1B(PTP1B)的能力,以此系列新型二苯并[b,d]呋喃单羧酸衍生物,以用作潜在的抗糖尿病药。结构-活性关系研究导致鉴定出有效化合物5 E,该化合物抑制PTP1B,IC(50)值为82 +/- 0.43 nM。使用马来酸罗格列酮作为标准品,体内筛选化合物5 E作为抗糖尿病活性的候选药物。化合物5 E在ob / ob小鼠中显示出体重,进食状态全血糖(WBG),空腹WBG,血浆葡萄糖和血浆胆固醇水平显着降低,并且空腹血浆甘油三酯水平显着降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号